LON:C4XD - C4X Discovery Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 43.25
▼ -0.5 (-1.14%)

This chart shows the closing price for C4XD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New C4X Discovery Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for C4XD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for C4XD

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for C4X Discovery in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 43.25.

This chart shows the closing price for C4XD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in C4X Discovery. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/27/2017Panmure GordonReiterated RatingBuyGBX 129
2/21/2017Panmure GordonInitiated CoverageBuyGBX 129
(Data available from 11/27/2016 forward)

News Sentiment Rating

1.50 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

C4X Discovery

C4X Discovery Holdings plc operates as a drug discovery and development company in the United Kingdom. It has a suite of proprietary technologies across the drug discovery process, including Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing and designing 4D molecules in virtual reality. The company's product pipeline comprises Oral Orexin-1, an antagonist for the treatment of substance abuse disorders; Oral NRF-2 activators, IL-17 inhibitors, and a4Ã7 integrin inhibitors for the treatment of inflammatory diseases; MALT-1 inhibitors for the treatment of hematological cancer; synthetic lethal novel targets for the treatment of colorectal and lung cancer; and various products for the treatment of neurodegenerative diseases. It has research collaboration agreements with the University of Bristol, the University of Reading, the University of Oxford, and the University of Manchester; and drug discovery partnerships with Indivior PLC, LifeArc, GTN LTD, PhoreMost, e-therapeutics plc, AstraZeneca UK Limited, Evotec, SGC-Oxford, and Horizon Discovery Ltd. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was founded in 2007 and is based in Manchester, the United Kingdom.
Read More

Today's Range

Now: GBX 43.25
Low: 41.80
High: 43.50

50 Day Range

MA: GBX 34.25
Low: 27.50
High: 44.75

52 Week Range

Now: GBX 43.25
Low: 10.10
High: 54.50

Volume

594,887 shs

Average Volume

499,234 shs

Market Capitalization

£98.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of C4X Discovery?

The following sell-side analysts have issued stock ratings on C4X Discovery in the last year:
View the latest analyst ratings for C4XD.

What is the current price target for C4X Discovery?

0 Wall Street analysts have set twelve-month price targets for C4X Discovery in the last year. has the lowest price target set, forecasting a price of £100,000 for C4X Discovery in the next year.
View the latest price targets for C4XD.

What is the current consensus analyst rating for C4X Discovery?

C4X Discovery currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for C4XD.

How do I contact C4X Discovery's investor relations team?

C4X Discovery's physical mailing address is 53 Portland Street, MANCHESTER, M1 3LD, United Kingdom. The company's listed phone number is +44-161-2355085. The official website for C4X Discovery is www.c4xdiscovery.com.